Pharma & Biotech
Idorsia Secures Major Funding Boost Through Oversubscribed Share Placement
Swiss biopharmaceutical firm Idorsia Ltd has successfully completed a significantly oversubscribed capital raise, generating CHF 65.6 million. The company placed...
Moderna’s Cancer Vaccine Breakthrough Sparks Investor Hope
Moderna, the pioneering vaccine developer, may be on the verge of its most significant achievement since its COVID-19 vaccine success....
AbbVie’s Profit Forecast Cut Sends Shockwaves Through Market
A substantial $2.7 billion charge has delivered a significant blow to biotechnology leader AbbVie, forcing the company to dramatically lower...
NuCana’s Pivotal Cancer Data Release Could Reshape Investment Outlook
A potentially transformative moment for NuCana shareholders arrives today as the European Society for Medical Oncology (ESMO) prepares to disclose...
Eli Lilly’s Strategic Expansion: High-Profile Hire and Billion-Dollar Investment Fuel Growth
Pharmaceutical leader Eli Lilly is making decisive moves to position itself for its next growth chapter, combining a strategic executive...
Danaher’s Divergence: Institutional Investors Clash Over Future Direction
A fascinating tug-of-war is unfolding among major financial institutions regarding Danaher Corporation, creating significant uncertainty around the life sciences giant's...
Amgen Investors Await Critical FDA Verdict on Blockbuster Drug Expansion
The investment community is closely monitoring Amgen as a pivotal regulatory decision approaches that could significantly impact the company's growth...
Walgreens Concludes Public Trading Era Following Landmark Acquisition
The stock market chapter for Walgreens Boots Alliance has officially closed. Sycamore Partners, a major private equity firm, has finalized...
BioNTech’s Strategic Pivot to Africa Amid Stock Market Challenges
BioNTech's corporate narrative is expanding beyond its Mainz headquarters, with Africa emerging as a crucial theater for its future operations....
Biotech Stock Surges as Insider Confidence Sparks Turnaround
After experiencing a severe decline that wiped out more than 80% of its value in September, aTyr Pharma is demonstrating...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
